Tous les communiqués | WebDisclosure

Switch to English

10964	Sociétés
240038	Mots-clés
168782	Articles
129139	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:38, il y a 28 jours 1 heure

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program (XS3146739993)
Turkiye Garanti Bankasi redeemed debt instrument as part of MTN program abroad, conforming to regulatory principles

Redemption Turkiye Garanti Bankasi MTN Program Debt Instrument Regulatory Principles
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:36, il y a 28 jours 1 heure

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program (XS3145801414)
Turkiye Garanti Bankasi A.S. redeem debt instrument issued under MTN program. Turkish version prevails in case of discrepancy. Conformity with regulations ensured

Investor Relations Turkiye Garanti Bankasi A.S. Redemption MTN Program Debt Instrument
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:33, il y a 28 jours 1 heure

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program (XS3146740066)
Turkiye Garanti Bankasi A.S. redeemed a debt instrument of 100.000.000 EUR issued under the Medium Term Note (MTN) program at abroad. Read more for details

Investor Relations Redemption Turkiye Garanti Bankasi MTN Program Debt Instrument
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:27, il y a 28 jours 2 heures

Inside Information / Operations of the issuer (acquisitions, sales...)
Innate Pharma prices €30 million offering of Ordinary Shares at €1.70 per share in Marseille, France. Proceeds will fund clinical development and ADC portfolio advancement

Ordinary Shares Clinical Development Offering Innate Pharma ADC Portfolio
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:27, il y a 28 jours 2 heures

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Innate Pharma annonce une augmentation de capital de 30 millions d’euros par l'émission de nouvelles actions ordinaires. Stifel et BTIG agissent en tant que coordinateurs. Utilisation des fonds pour le développement clinique et les besoins généraux

Augmentation De Capital Actions Ordinaires Innate Pharma Stifel BTIG
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:23, il y a 28 jours 2 heures

Safe Pro Group and the U.S. Army Enter Cooperative Research and Development Agreement for Unified Intelligence
Aventura, Florida, USA, August 14th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:23, il y a 28 jours 2 heures

Safe Pro Group and the U.S. Army Enter Cooperative Research and Development Agreement for Unified Intelligence
Aventura, Florida, August 14th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:23, il y a 28 jours 2 heures

ZenaTech's ZenaDrone Begins In-House PCB Flight Tests, Advancing Toward NDAA-Compliant Blue UAS Certification
Vancouver, British Columbia, August 14th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:15, il y a 28 jours 2 heures

DREO to Unveil New Air Products, Technologies and Air Intelligence at IFA 2026
DREO to unveil new Air Purifier lineup, heating technologies, and Air Intelligence at IFA 2026 in Berlin, showcasing innovative smart home solutions for air management

Heating Technologies IFA 2026 DREO Air Purifier Air Intelligence
COMMUNIQUÉ DE PRESSE

publié le 14/08/2026 à 10:00, il y a 28 jours 2 heures

Vossloh expands its digital offering with Cordel
Vossloh expands digital offering with Cordel acquisition, enhancing rail track inspection capabilities with LiDAR technology and artificial intelligence for predictive maintenance

Digital Offering Predictive Maintenance Vossloh Lidar Technology Cordel

Les Echos

Publié le 11/09/2026 à 07:00, il y a 5 heures 27 minutes

Transparantiekennisgeving van Baltisse Groep
Publié le 11/09/2026 à 07:00, il y a 5 heures 27 minutes

Transparency notification by Baltisse Group
Publié le 11/09/2026 à 07:00, il y a 5 heures 27 minutes

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 5 heures 27 minutes

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 16 heures 57 minutes

Availability of the 2026 Interim Financial Report

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 11/09/2026 à 04:00, il y a 8 heures 27 minutes

Torq Announces Debt Settlement and Corporate Update
Publié le 10/09/2026 à 22:25, il y a 14 heures 2 minutes

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Publié le 10/09/2026 à 17:46, il y a 18 heures 41 minutes

Groete Access Road Nears Completion
Publié le 10/09/2026 à 15:20, il y a 21 heures 7 minutes

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 21 heures 27 minutes

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

Voir tout ACCESSWIRE

EQS Group

Publié le 11/09/2026 à 11:45, il y a 41 minutes

Halfords Group PLC: Result of AGM
Publié le 11/09/2026 à 11:43, il y a 44 minutes

Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Publié le 11/09/2026 à 11:35, il y a 51 minutes

EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Publié le 11/09/2026 à 11:30, il y a 57 minutes

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Publié le 11/09/2026 à 10:15, il y a 2 heures 12 minutes

TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050